GlassScriptPhysician profile
Steve C Yun
NPI 1750340634
$181,550.52
in general payments reported to CMS, 2019-2025
7 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $41K · 2021: $45K · 2022: $17K · 2023: $31K · 2024: $14K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Royalty Or License: $2,355 · Travel and Lodging: $797 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,315.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,087.50 |
| Royalty Or License | $2,354.80 |
| Travel and Lodging | $796.61 |
| Food and Beverage | $271.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hf Acquisition Co. LLC | $81,852.69 | 2019-2025 | |
| Acelrx Pharmaceuticals, INC. | $79,715.96 | 2019-2023 | Dsuvia |
| Strategic Dentistry LLC | $19,547.13 | 2020-2023 | |
| Chiesi USA, INC. | $144.26 | 2021 | |
| Heron Therapeutics, INC. | $120.35 | 2025 | Zynrelef, Aponvie |
| Vyaire Medical, INC. | $119.74 | 2022 | |
| Sonendo INC | $50.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Yun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.